Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 20 October 2008, doi:10.1136/bmj.a2185
Cite this as: BMJ 2008;337:a2185
Lynn Eaton
1 London
| The first 150 words of the full text of this article appear below. |
Angioplasty is to become the treatment of choice in England for people who have a myocardial infarction, the Department of Health has announced, with 97% of patients expected to be having the procedure in specialist heart attack centres by 2011.
Results of a three year study involving 2400 patients treated in 10 hospitals across England show that primary angioplasty is feasible and cost effective.
Provided that the procedure is carried out within two hours of a heart attack, death rates are lower than with thrombolysis, the current standard treatment, and hospital stays are shorter, says a report of the study.
Roger Boyle, Englands clinical director for heart disease and stroke, said that the 30 day mortality rate for thrombolysis is 7%, but this reduces to 5% for angioplasty if it is given within two hours. In some parts of the country, such as London, regional death rates have been reduced
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?